Evidence map›Paper›PMID 42692520›Full record

ArticleBMJ open2026

Quality indicators for transcatheter aortic valve implantation in Ontario, Canada: a population-based study.

Suleman Aktaa, Olivia Haldenby, Feng Qiu, Dennis T Ko, Stephen Fremes, Maneesh Sud, Sandra B Lauck, Mamas A Mamas, Daniel J Blackman, John G Webb and 1 more

Abstract read
In one paragraph

Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Suleman AktaaCardiology, St Paul's Hospital, Vancouver, British Columbia, Canada.ORCID http://orcid.org/0009-0004-7900-2742
Olivia HaldenbyInstitute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Feng QiuInstitute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Dennis T KoMedicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Stephen FremesSchulich Heart Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0003-1723-3049
Maneesh SudInstitute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Sandra B LauckCardiology, St Paul's Hospital, Vancouver, British Columbia, Canada.
Mamas A MamasInstitute for Science & Technology in Medicine, Keele University, Keele, UK.ORCID http://orcid.org/0000-0001-9241-8890
Daniel J BlackmanLeeds General Infirmary, Leeds, UK.
John G WebbCentre for Cardiovascular Innovation, St Paul's Hospital, Vancouver, British Columbia, Canada.
Harindra C WijeysunderaInstitute for Clinical Evaluative Sciences, Toronto, Ontario, Canada harindra.wijeysundera@sunnybrook.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe examined the utility of quality indicators (QIs) for transcatheter aortic valve implantation (TAVI) in the assessment of TAVI care quality and variation in practice.

designWe performed a retrospective population-level cohort study in Ontario, Canada, where all residents receive publicly funded universal medical care. We examined the association between QI attainment and outcomes using multivariable hierarchical logistic models. We used median ORs to understand if variation in clinical outcomes between hospitals was attributable to variation in QI attainment.

settingWe used all-comer registry data from the provincial CorHealth registry in Ontario, with linkage to administrative datasets using unique patient encoded identifiers.

participantsTAVI recipients between 2018 and 2023 in Ontario, Canada.

interventionWe derived a unique set of QIs from internationally agreed ones. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary endpoint was a composite of all-cause mortality or rehospitalisation at 1 year from the date of TAVI.

resultsData from 9748 TAVI procedures were included between 2018 and 2023. We identified five feasible QIs, the majority of which had high compliance and minimal variation; the lone exception was the performance of transfemoral TAVI without general anaesthesia (median 0.87; IQR 0.78-0.93). Adherence to QIs was associated with a reduction in the composite endpoint. The strongest association was observed with multidisciplinary heart team involvement (defined as the presence of an interventional cardiologist and a cardiac surgeon) in the TAVI procedure (OR 0.67, 95% CI 0.50 to 0.90, p=0.007), the performance of transfemoral TAVI without general anaesthesia (OR 0.80, 95% CI 0.71 to 0.91, p<0.0004) and the utilisation of the transfemoral access (OR 0.84, 95% CI 0.69 to 1.04, p=0.10). However, variation in clinical outcomes following TAVI between hospitals was not attributable to variation in QI attainment. Falsification analysis suggests substantial residual confounding.

conclusionsWe developed a feasible set of QIs for TAVI and validated these QIs using routinely collected data from a large all-comer registry in Ontario. We have identified overall high quality of care for TAVI, but with some variation in practice, which in part is attributable to differences in patient factors. Our work suggests that QIs can inform quality improvement efforts by prompting future work into discretionary versus non-discretionary variation.

Indexed as

Aortic Valve StenosisQuality Indicators, Health CareTranscatheter Aortic Valve ReplacementAgedAged, 80 and overFemaleHumansLogistic ModelsMaleOntarioPatient ReadmissionRegistriesRetrospective StudiesAuditQuality ImprovementQuality in health careValvular heart disease

Identifiers

PMID42692520
PMCPMC13548211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.